Type 2 diabetesmedications have beengrowing in popularityover the last several years. And they all belong to the same class — glucagon-like peptide-1 (GLP-1) agonists.GLP-1 agonistswork by triggering insulin release, reducing glucose (sugar) production in your liver, and making you feel full...